Quarterly ResultNov 5, 2026, 06:09 AM
LifeStance Health Q3 Revenue $455.9M (+25% YoY); Raises Full Year Outlook
AI Summary
LifeStance Health Group announced strong third quarter 2026 financial results, with revenue increasing 25% year-over-year to $455.9 million and net income rising to $22.4 million from $1.1 million in the prior year. The company also raised its full-year 2026 financial outlook across key metrics including revenue, Center Margin, and Adjusted EBITDA. The growth was driven by increased visit volumes and a growing clinician base.
Key Highlights
- LifeStance Health Group reported Q3 2026 revenue of $455.9 million, a 25% increase year-over-year.
- Net income for Q3 2026 was $22.4 million, a significant increase from $1.1 million in Q3 2025.
- Adjusted EBITDA rose 70% to $68.4 million in Q3 2026.
- The company raised its full-year 2026 revenue guidance to $1.741 billion - $1.761 billion.
- Clinician base grew 11% year-over-year to 8,863.
- Third quarter visit volumes increased 17% to 2.7 million.
Price Impact
More from LFST